Connect-to-Translate

  1. Home
    2.  » Association

Ksilink has created a public-private Association, enabling seamless alignment from academic excellence to preclinical candidate development.

Today, the Association, allows the Ksilink company to get access to internationally renowned institutes, hospitals and platforms, with the mission to foster patient-based drug discovery for the pharmaceutical industry.

Ksilink's partners KOL

Staying at the cutting edge of clinical know-how and development ​

Ksilink has created a strategic alliance – the Ksilink Association – with leading European institutions and their KOL’s. This competence network offers Ksilink e.g. privileged access to stem cells derived from patients and patient cohorts as well as cutting edge technologies and latest clinical developments.

Associating the most competent partners in each disease area

From high scale standardized production of differentiated patient-based cells to preclinical development of novel molecular entities: the Ksilink Association builds a translational hub gathering most competent partners in each area.

 Securing translational feasibility ​

Contributing to an integrated value chain, our partners ensure translational feasibility and market access. Partners are connected to Ksilink through different gateways, from a specific project collaboration to a membership within the Ksilink Association. Ksilink’s network is constantly expanding and allow us to address drug discovery challenges as a team.

The Ksilink Association : Building the bridge!

Scientific achievements require team spirit, time and consistency. The Ksilink Association allows for a multidisciplinary effort to foster patient-based drug discovery, increasing our chances to effectively translate scientific excellence into new treatments for patients.

Today the Association consists of 10 members: